What is Stella Diagnostics Inc. (SLDX)?

Stella Diagnostics Inc. (SLDX) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of SLDX?

The current price of SLDX is $0.01. Prices are updated in real time on Stocks360.

What is SLDX's price-to-earnings (PE) ratio?

SLDX's trailing twelve-month PE ratio is -0.71, based on current price and earnings per share data available on Stocks360.

What is SLDX's market capitalization?

SLDX's market capitalization is $3,015,050.00, placing it in the small-cap tier.

Stella Diagnostics Inc. (SLDX)

Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research

$0.01

Market Cap

$3.02M

PE (TTM)

-0.71

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.21

Day Range

$0.01 – $0.01

52-wk Range

$0.01 – $0.03

Avg Volume

N/A

Volume

1.00

Stella Diagnostics Inc. (SLDX) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $3.02M. Trailing PE -0.71. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.02 2026-10-26 · $0.01 (-33.33%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Stella Diagnostics Inc.

Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.71×
P/S (TTM)	1.79×
P/B	-0.10×
PEG	0.01×
P/FCF (TTM)	-1.27×
EV / EBITDA	-4.17×
EV / Sales	10.16×
Earnings Yield	-144.45%
Free Cash Flow Yield	-78.44%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$17.12M
Revenue (TTM)	$1.69M
Net Income (TTM)	-$4.36M
Free Cash Flow (TTM)	-$2.12M
Net Debt	$14.11M
Working Capital	-$28.99M
Gross Margin	-21.65%
Operating Margin	-243.70%
Net Margin	-258.33%
Return on Equity	15.97%
Return on Invested Capital	27.71%